600976.SH上海证券交易所 · 主板 Main
Jianmin Group 健民集团
Traditional Chinese Medicine 中药Ⅱ
¥26.80−¥0.22 · −0.81%
Open 开盘
¥27.00
High 最高
¥27.17
Low 最低
¥26.70
Prev Close 昨收
¥27.02
Volume 成交量
68.1万股
Turnover 成交额
¥1,829.1万
Mkt Cap 总市值
¥41亿
P/E 市盈率
13.0×
Recent Activity 近期动态All Filings 全部公告 →
1 broker report from 1 firm since 31 May 2026, the latest on 25 Aug 2026.
自 31 May 2026 起有 1 份研报，来自 1 家券商，最新一份见于 25 Aug 2026。
25.0027.5030.0032.5035.0037.5040.00
Volume 成交量
879.4万
Sep 25Dec 25Mar 26Jun 26Sep 26
Overview 概览Deep Report 深度报告Financials 财务Valuation 估值Ownership 股东Analysts 券商Estimates 预测News 动态Events 事件Peers 同业
Last Twelve Months 近十二个月
2 reports from 1 broker · 2 unrated 1 家券商 2 份研报，2 份无评级
Reports Share Market
Buy 买入 0 — 70.7%
Outperform 增持 0 — 28.6%
Neutral 中性 0 — 0.7%
Underperform 减持 0 — 0.0%
Sell 卖出 0 — 0.0%
The tick on each bar marks the whole market, where 99.3% of rated reports in the same twelve months said Buy or Outperform. 刻度线为全市场水平：同期 99.3% 的评级为买入或跑赢。
Rating Changes 评级变动
1 up · 0 down in all reports held 全部研报中上调 1 次，下调 0 次
| Date 日期 | Broker 券商 | Analyst 分析师 | From 原评级 | To 新评级 | |
|---|---|---|---|---|---|
| 27 Mar 2025 | 信达证券 | 唐爱金,章钟涛 | Outperform 增持 | ▲ | Buy 买入 |
Each broker's rating is compared with its previous report. 每家券商的评级与其上一份研报比较。
Current Coverage 当前覆盖
| Broker 券商 | Analyst 分析师 | Latest Rating 最新评级 | Date 日期 | Reports 研报 | Target 目标价 |
|---|---|---|---|---|---|
| 西南证券 | 杜向阳 | Unrated | 25 Aug 2026 | 2 | — |
Each row is a broker's latest report in the last twelve months. A price target is given in 0 of 2 reports. 每行为该券商近十二个月的最新研报；2 份中 0 份给出目标价。
Coverage by Quarter 覆盖变化
2 23Q4
3 24Q1
0 24Q2
3 24Q3
0 24Q4
2 25Q1
1 25Q2
0 25Q3
1 25Q4
0 26Q1
0 26Q2
1 26Q3
Each bar counts the brokers publishing on this company in a quarter. The latest quarter is not yet complete. 每根柱为该季度发布本公司研报的券商数，最近一个季度尚未结束。